| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $112,207,142 | 46 | 100 |
| Zaks Tal Zvi | director | 0 | $0 | 1 | $593 | $-593 |
| Satchi-Fainaro Ronit | director | 0 | $0 | 1 | $15,459 | $-15,459 |
| Savage Brian | Interim Chief Legal Officer | 0 | $0 | 4 | $448,975 | $-448,975 |
| Jover Placid | See "Remarks" | 0 | $0 | 2 | $895,458 | $-895,458 |
| Shields Matthew | EVP, Global Operations | 0 | $0 | 3 | $1.4M | $-1.4M |
| Weiss Amir | Chief Accounting Officer | 0 | $0 | 4 | $1.41M | $-1.41M |
| Lippman Evan | EVP, Business Development | 0 | $0 | 2 | $2.16M | $-2.16M |
| Fox Christine | EVP, Head of U.S. Commercial | 0 | $0 | 5 | $2.75M | $-2.75M |
| Hughes Eric A | See "Remarks" | 0 | $0 | 4 | $4.17M | $-4.17M |
| Daniell Richard | Exec. VP, European Commercial | 0 | $0 | 5 | $10.99M | $-10.99M |
| Sabag Mark | See "Remarks" | 0 | $0 | 3 | $13.15M | $-13.15M |
| Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 0 | $0 | 3 | $20.73M | $-20.73M |
| MIGNONE ROBERTO | director | 0 | $0 | 4 | $22.82M | $-22.82M |
| Francis Richard D | President and CEO | 0 | $0 | 5 | $31.26M | $-31.26M |
Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical …
Over the last 12 months, insiders at Teva Pharmaceutical Industries Limited have bought $0 and sold $112.21M worth of Teva Pharmaceutical Industries Limited stock.
On average, over the past 5 years, insiders at Teva Pharmaceutical Industries Limited have bought $20,988 and sold $34.32M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,113 shares for transaction amount of $20,988 was made by McAvoy David R. (EVP, Chief Legal Officer) on 2025‑09‑05.
| 2026-09-18 | Sale | Savage Brian | Interim Chief Legal Officer | 7,342 0.0006% | $38.85 | $285,215 | +2.96% | |
| 2026-09-18 | Sale | MIGNONE ROBERTO | director | 367,600 0.0316% | $39.06 | $14.36M | +2.96% | |
| 2026-08-21 | Sale | Satchi-Fainaro Ronit | director | 415 <0.0001% | $37.25 | $15,459 | +5.28% | |
| 2026-08-21 | Sale | Weiss Amir | Chief Accounting Officer | 9,445 0.0008% | $37.62 | $355,301 | +5.28% | |
| 2026-08-17 | Sale | Lippman Evan | EVP, Business Development | 18,600 0.0016% | $36.57 | $680,291 | +7.65% | |
| 2026-08-05 | Sale | Zaks Tal Zvi | director | 17 <0.0001% | $34.87 | $593 | +12.70% | |
| 2026-08-03 | Sale | Hughes Eric A | See "Remarks" | 25,578 0.0022% | $34.88 | $892,051 | +13.20% | |
| 2026-08-03 | Sale | Jover Placid | See "Remarks" | 12,827 0.0011% | $34.88 | $447,351 | +13.20% | |
| 2026-06-18 | Sale | Shields Matthew | EVP, Global Operations | 9,989 0.0009% | $32.19 | $321,547 | +16.80% | |
| 2026-06-11 | Sale | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 106,563 0.009% | $34.10 | $3.63M | +6.13% | |
| 2026-06-05 | Sale | Francis Richard D | President and CEO | 6,153 0.0005% | $34.35 | $211,356 | +6.90% | |
| 2026-06-03 | Sale | Shields Matthew | EVP, Global Operations | 16,195 0.0014% | $32.87 | $532,330 | +11.18% | |
| 2026-05-14 | Sale | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | 153,251 0.0133% | $35.61 | $5.46M | +2.35% | |
| 2026-05-14 | Sale | Lippman Evan | EVP, Business Development | 41,658 0.0036% | $35.58 | $1.48M | +2.35% | |
| 2026-05-06 | Sale | Weiss Amir | Chief Accounting Officer | 10,679 0.0009% | $36.00 | $384,444 | -0.91% | |
| 2026-05-05 | Sale | Daniell Richard | EVP, Europe Commercial | 30,000 0.0025% | $35.40 | $1.06M | +0.47% | |
| 2026-05-01 | Sale | Sabag Mark | See "Remarks" | 144,180 0.0124% | $34.99 | $5.05M | +2.82% | |
| 2026-04-30 | Sale | Fox Christine | EVP, U.S. Commercial | 21,258 0.0018% | $35.31 | $750,620 | +2.25% | |
| 2026-03-17 | Sale | Sabag Mark | See "Remarks" | 62,102 0.0053% | $30.14 | $1.87M | +15.37% | |
| 2026-03-05 | Sale | Francis Richard D | President and CEO | 20,025 0.0017% | $31.67 | $634,160 | +9.09% |
| MIGNONE ROBERTO | director | 0 0% | $0 | 2 | 6 | +9.88% |
| BARER SOL J | director | 220442 0.0189% | $9.24M | 2 | 0 | +0.5% |
| Dethlefs Sven | EVP, North America Commercial | 165381 0.0142% | $6.93M | 1 | 17 | <0.0001% |
| McAvoy David R. | EVP, Chief Legal Officer | 13027 0.0011% | $545,961.57 | 1 | 0 | +67.07% |
$1,279,728,023 | 131 | 10.76% | $3.05B | |
$25,613,591 | 65 | -3.30% | $12.27B | |
$14,599,168 | 59 | 12.79% | $1.66B | |
$102,709,455 | 46 | 30.55% | $1.45B | |
$73,762,556 | 45 | -9.99% | $2.17B |
| Increased Positions | 340 | +57.82% | 127M | +18.37% |
| Decreased Positions | 242 | -41.16% | 126M | -18.23% |
| New Positions | 130 | New | 24M | New |
| Sold Out Positions | 50 | Sold Out | 26M | Sold Out |
| Total Postitions | 686 | +16.67% | 693M | +0.14% |
| Blackrock, Inc. | $1.79M | 5.04% | 57.8M | +3M | +6.41% | 2025-09-30 |
| Phoenix Financial Ltd. | $1.28M | 3.6% | 41.3M | +4M | +9.36% | 2025-09-30 |
| Menora Mivtachim Holdings Ltd. | $1.2M | 3.39% | 38.92M | +427,000 | +1.11% | 2025-09-30 |
| Harel Insurance Investments & Financial Services Ltd. | $1.17M | 3.29% | 37.7M | +4M | +12.9% | 2025-09-30 |
| Migdal Insurance & Financial Holdings Ltd. | $1.01M | 2.84% | 32.58M | +4M | +13.59% | 2025-09-30 |
| Clal Insurance Enterprises Holdings Ltd | $974,513.00 | 2.75% | 31.49M | -876,000 | -2.71% | 2025-09-30 |
| Lingotto Investment Management Llp | $884,823.00 | 2.49% | 28.59M | +431,872 | +1.53% | 2025-09-30 |
| Rubric Capital Management Lp | $762,918.00 | 2.15% | 24.65M | -1M | -5.19% | 2025-09-30 |
| Fmr Llc | $762,650.00 | 2.15% | 24.64M | -33M | -57.61% | 2025-09-30 |
| Pointstate Capital Lp | $641,049.00 | 1.81% | 20.71M | 0 | 0% | 2025-09-30 |